Nancy Grygiel serves as senior vice president and chief compliance officer, responsible for Amgen’s Compliance, Global Privacy, and Trade organization. Grygiel joined Amgen in 2015 as vice president of Compliance, responsible for overseeing Amgen’s healthcare and anti-corruption compliance programs in all markets. In addition, Grygiel has been accountable for reporting on the status and effectiveness of the program’s elements, and ongoing activities to Amgen’s CEO operating teams, and to the company’s Corporate Responsibility and Compliance Committee (CRCC), on an ongoing basis.

Prior to joining Amgen, Grygiel served as vice president, Compliance, at Allergan. In that role, she was responsible for the implementation and execution of the corporate compliance program’s global strategy. In addition, Grygiel led cross-functional compliance-related efforts and served as an advisor to the corporate audit function on Foreign Corrupt Practices Act and other applicable in-country healthcare laws and regulations.

Prior to her time at Allergan, Grygiel held positions of increasing responsibility at Mylan Pharmaceuticals, where she developed and established the export controls and international compliance program, as a result of the company’s rapid global expansion in 2007.

Earlier in her career, Grygiel worked in the legal field with a focus on international laws, transnational business transactions and export-control laws. She also held in-house legal roles within the telecommunications industry in her home country of Argentina.

Grygiel has a law degree from Buenos Aires University and a Master of Laws degree (LL.M) from Georgetown University Law Center.